Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,961 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Editorial: Autoimmune blistering diseases, volume II.
Li X, Di Zenzo G, Schmidt E, Joly P, Hashimoto T. Li X, et al. Among authors: schmidt e. Front Immunol. 2023 Mar 16;14:1175962. doi: 10.3389/fimmu.2023.1175962. eCollection 2023. Front Immunol. 2023. PMID: 37006261 Free PMC article. No abstract available.
Current treatment of autoimmune blistering diseases.
Kasperkiewicz M, Schmidt E. Kasperkiewicz M, et al. Among authors: schmidt e. Curr Drug Discov Technol. 2009 Dec;6(4):270-80. doi: 10.2174/157016309789869065. Curr Drug Discov Technol. 2009. PMID: 20025595 Review.
Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
Schmidt E, Dähnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, Stöcker W, Hashimoto T, Bröcker EB, Recke A, Rose C, Zillikens D. Schmidt E, et al. Exp Dermatol. 2010 May;19(5):458-63. doi: 10.1111/j.1600-0625.2010.01069.x. Epub 2010 Feb 16. Exp Dermatol. 2010. PMID: 20163452
Development of NC1 and NC2 domains of type VII collagen ELISA for the diagnosis and analysis of the time course of epidermolysis bullosa acquisita patients.
Saleh MA, Ishii K, Kim YJ, Murakami A, Ishii N, Hashimoto T, Schmidt E, Zillikens D, Shirakata Y, Hashimoto K, Kitajima Y, Amagai M. Saleh MA, et al. Among authors: schmidt e. J Dermatol Sci. 2011 Jun;62(3):169-75. doi: 10.1016/j.jdermsci.2011.03.003. Epub 2011 Mar 16. J Dermatol Sci. 2011. PMID: 21482078
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.
Murrell DF, Daniel BS, Joly P, Borradori L, Amagai M, Hashimoto T, Caux F, Marinovic B, Sinha AA, Hertl M, Bernard P, Sirois D, Cianchini G, Fairley JA, Jonkman MF, Pandya AG, Rubenstein D, Zillikens D, Payne AS, Woodley D, Zambruno G, Aoki V, Pincelli C, Diaz L, Hall RP, Meurer M, Mascaro JM Jr, Schmidt E, Shimizu H, Zone J, Swerlick R, Mimouni D, Culton D, Lipozencic J, Bince B, Grando SA, Bystryn JC, Werth VP. Murrell DF, et al. Among authors: schmidt e. J Am Acad Dermatol. 2012 Mar;66(3):479-85. doi: 10.1016/j.jaad.2011.06.032. Epub 2011 Nov 5. J Am Acad Dermatol. 2012. PMID: 22056920 Free PMC article.
3,961 results